Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

PFO and Treasurer

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-28	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-28	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-28	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-28	Premium	sold	Premium	Premium	Premium	President and CEO
2022-05-25	Premium	sold	Premium	Premium	Premium	-
2022-05-25	Premium	acquired	Premium	Premium	Premium	-
2021-06-29	Premium	acquired	Premium	Premium	Premium	PFO and Treasurer
2021-06-29	Premium	sold	Premium	Premium	Premium	PFO and Treasurer
2021-06-29	Premium	sold	Premium	Premium	Premium	President and CEO
2021-06-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-05-21	Premium	sold	Premium	Premium	Premium	-
2021-05-21	Premium	acquired	Premium	Premium	Premium	-
2021-05-17	Premium	bought	Premium	Premium	Premium	-
2021-02-24	Premium	sold	Premium	Premium	Premium	-
2021-02-24	Premium	acquired	Premium	Premium	Premium	-
2021-02-19	Premium	bought	Premium	Premium	Premium	-

AVXL - Anavex Life Sciences Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for AVXL